Search

everythinglearnresearchcommunity

for

Search:↓

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Some cats with sudden hair loss and tiredness might have cancer-related alopecia.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Thyroxine can adjust the body's peripheral clock, potentially helping treat clock-related diseases.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Children with trichotillomania often pull hair from their scalp, and parents may not notice; stress can trigger it, and asking detailed questions helps in diagnosis and treatment.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Intersex frogs have different brain gene activity related to sex and thyroid hormones.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Genetic discoveries are key for understanding, diagnosing, and treating inherited hair and nail disorders.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.